AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
EFFECTS OF SYSTEMIC TREATMENT WITH LIAROZOLE ON CUTANEOUS INFLAMMATION, EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN EXTENSIVE PLAQUE PSORIASIS
Authors: VANPELT JPA DEJONG EMGJ BAKKER ESM VANDEKERKHOF PCM
Citation: Jpa. Vanpelt et al., EFFECTS OF SYSTEMIC TREATMENT WITH LIAROZOLE ON CUTANEOUS INFLAMMATION, EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN EXTENSIVE PLAQUE PSORIASIS, SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 11(2), 1998, pp. 70-79
THE EFFICACY OF A NEW TOPICAL TREATMENT FOR PSORIASIS - MIRAK
Authors: SEYGER MMB VANDEKERKHOF PCM VANVLIJMENWILLEMS IMJJ DEBAKKER ESM ZWIERS F DEJONG EMGJ
Citation: Mmb. Seyger et al., THE EFFICACY OF A NEW TOPICAL TREATMENT FOR PSORIASIS - MIRAK, JEADV. Journal of the European Academy of Dermatology and Venereology, 11(1), 1998, pp. 13-18
THE CD11B CD18-INTEGRIN IN THE PATHOGENESIS OF PSORIASIS/
Authors: VANPELT JPA KUIJPERS SHH VANDEKERKHOF PCM DEJONG EMGJ
Citation: Jpa. Vanpelt et al., THE CD11B CD18-INTEGRIN IN THE PATHOGENESIS OF PSORIASIS/, Journal of dermatological science, 16(2), 1998, pp. 135-143
LOW-DOSE METHOTREXATE IN THE TREATMENT OF WIDESPREAD MORPHEA
Authors: SEYGER MMB VANDENHOOGEN FHJ DEBOO T DEJONG EMGJ
Citation: Mmb. Seyger et al., LOW-DOSE METHOTREXATE IN THE TREATMENT OF WIDESPREAD MORPHEA, Journal of the American Academy of Dermatology, 39(2), 1998, pp. 220-225
LINEAR LICHEN-PLANOPILARIS OF THE FACE
Authors: GERRITSEN MJP DEJONG EMGJ VANDEKERKHOF PCM
Citation: Mjp. Gerritsen et al., LINEAR LICHEN-PLANOPILARIS OF THE FACE, Journal of the American Academy of Dermatology, 38(4), 1998, pp. 633-635
LOCALIZED AND SYSTEMIC SCLERODERMA SHOW DIFFERENT HISTOLOGICAL RESPONSES TO METHOTREXATE THERAPY
Authors: SEYGER MMB VANDENHOOGEN FHJ VANVLIJMENWILLEMS IMJJ VANDEKERKHOF PCM DEJONG EMGJ
Citation: Mmb. Seyger et al., LOCALIZED AND SYSTEMIC SCLERODERMA SHOW DIFFERENT HISTOLOGICAL RESPONSES TO METHOTREXATE THERAPY, Journal of investigative dermatology, 110(4), 1998, pp. 602-602
EFFECTS OF SYSTEMIC TREATMENT WITH LIAROZOLE ON CUTANEOUS INFLAMMATION, EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN EXTENSIVE PLAQUE PSORIASIS
Authors: VANPELT JPA DEJONG EMGJ DEBAKKER ESM VANDEKERKHOF PCM
Citation: Jpa. Vanpelt et al., EFFECTS OF SYSTEMIC TREATMENT WITH LIAROZOLE ON CUTANEOUS INFLAMMATION, EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN EXTENSIVE PLAQUE PSORIASIS, Journal of investigative dermatology, 110(4), 1998, pp. 643-643
INVESTIGATION ON A NOVEL AND SPECIFIC LEUKOTRIENE B-4 RECEPTOR ANTAGONIST IN THE TREATMENT OF STABLE PLAQUE PSORIASIS
Authors: VANPELT JPA DEJONG EMGJ SEIJGER MMB VANHOOIJDONK CAEM DEBAKKER ESM VANVLIJMEN IMJJ PARKER GL VANERP PEJ VANDEKERKHOF PCM
Citation: Jpa. Vanpelt et al., INVESTIGATION ON A NOVEL AND SPECIFIC LEUKOTRIENE B-4 RECEPTOR ANTAGONIST IN THE TREATMENT OF STABLE PLAQUE PSORIASIS, British journal of dermatology, 139(3), 1998, pp. 396-402
DECREASED STAINING OF HEPARAN-SULFATE IN NON-LESIONAL SKIN OF A SUBGROUP OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: SEYGER MMB VANBRUGGEN MCJ HARDEMAN HK VANDENHOOGEN FHJ BERDEN JHM VANDENBORN J DEJONG EMGJ
Citation: Mmb. Seyger et al., DECREASED STAINING OF HEPARAN-SULFATE IN NON-LESIONAL SKIN OF A SUBGROUP OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Acta dermato-venereologica, 78(5), 1998, pp. 326-330
EXPRESSION OF ENDOGLIN IN THE TRANSITION BETWEEN PSORIATIC UNINVOLVEDAND INVOLVED SKIN
Authors: VANDEKERKHOF PCM RULO HFC VANPELT JPA VANVLIJMENWILLEMS IMJJ DEJONG EMGJ
Citation: Pcm. Vandekerkhof et al., EXPRESSION OF ENDOGLIN IN THE TRANSITION BETWEEN PSORIATIC UNINVOLVEDAND INVOLVED SKIN, Acta dermato-venereologica, 78(1), 1998, pp. 19-21
DECREASED CD11B EXPRESSION ON CIRCULATING POLYMORPHONUCLEAR LEUKOCYTES IN PATIENTS WITH EXTENSIVE PLAQUE PSORIASIS
Authors: VANPELT JPA DEJONG EMGJ VANERP PEJ VANDEKERKHOF PCM
Citation: Jpa. Vanpelt et al., DECREASED CD11B EXPRESSION ON CIRCULATING POLYMORPHONUCLEAR LEUKOCYTES IN PATIENTS WITH EXTENSIVE PLAQUE PSORIASIS, EJD. European journal of dermatology, 7(5), 1997, pp. 324-328
THE EPIDERMIS AS A TARGET FOR ANTIPSORIATIC TREATMENT - THE NIJMEGEN VIEW
Authors: VANDEKERKHOF PCM VANDERVLEUTEN CJM GERRITSEN MJP DEJONG EMGJ
Citation: Pcm. Vandekerkhof et al., THE EPIDERMIS AS A TARGET FOR ANTIPSORIATIC TREATMENT - THE NIJMEGEN VIEW, Journal of dermatological treatment, 8(3), 1997, pp. 203-210
RECRUITMENT OF CYCLING EPIDERMAL-CELLS AND EXPRESSION OF FILAGGRIN, INVOLUCRIN AND TENASCIN IN THE MARGIN OF THE ACTIVE PSORIATIC PLAQUE, IN THE UNINVOLVED SKIN OF PSORIATIC PATIENTS AND IN THE NORMAL HEALTHY SKIN
Authors: GERRITSEN MJP ELBERS ME DEJONG EMGJ VANDEKERKHOF PCM
Citation: Mjp. Gerritsen et al., RECRUITMENT OF CYCLING EPIDERMAL-CELLS AND EXPRESSION OF FILAGGRIN, INVOLUCRIN AND TENASCIN IN THE MARGIN OF THE ACTIVE PSORIATIC PLAQUE, IN THE UNINVOLVED SKIN OF PSORIATIC PATIENTS AND IN THE NORMAL HEALTHY SKIN, Journal of dermatological science, 14(3), 1997, pp. 179-188
THE COURSE OF PSORIASIS
Authors: DEJONG EMGJ
Citation: Emgj. Dejong, THE COURSE OF PSORIASIS, Clinics in dermatology, 15(5), 1997, pp. 687-692
EPICUTANEOUS APPLICATION OF LEUKOTRIENE B-4 INDUCES PATTERNS OF TENASCIN AND A HEPARAN-SULFATE PROTEOGLYCAN EPITOPE THAT ARE TYPICAL FOR PSORIATIC LESIONS
Authors: SEYGER MMB VANPELT JPA VANDENBORN J LATIJNHOUWERS MA DEJONG EMGJ
Citation: Mmb. Seyger et al., EPICUTANEOUS APPLICATION OF LEUKOTRIENE B-4 INDUCES PATTERNS OF TENASCIN AND A HEPARAN-SULFATE PROTEOGLYCAN EPITOPE THAT ARE TYPICAL FOR PSORIATIC LESIONS, Archives of dermatological research, 289(6), 1997, pp. 331-336
RELIABILITY OF 2 METHODS TO ASSESS MORPHEA - SKIN SCORING AND THE USEOF A DUROMETER
Authors: SEYGER MMB VANDENHOOGEN FHJ DEBOO T DEJONG EMGJ
Citation: Mmb. Seyger et al., RELIABILITY OF 2 METHODS TO ASSESS MORPHEA - SKIN SCORING AND THE USEOF A DUROMETER, Journal of the American Academy of Dermatology, 37(5), 1997, pp. 793-796
DECREASED STAINING OF HEPARAN-SULFATE PROTEOGLYCANS IN NON LESIONAL SKIN OF A SUBGROUP OF SLE PATIENTS
Authors: SEYGER MMB VANBRUGGEN MCJ HARDEMAN H VANDENHOOGEN FHJ BERDEN JHM VANDENBORN J DEJONG EMGJ
Citation: Mmb. Seyger et al., DECREASED STAINING OF HEPARAN-SULFATE PROTEOGLYCANS IN NON LESIONAL SKIN OF A SUBGROUP OF SLE PATIENTS, Journal of investigative dermatology, 109(3), 1997, pp. 421-421
EXTREMELY LOW-LEVELS OF EPIDERMAL SKIN-DERIVED ANTILEUCOPROTEINASE ELAFIN IN A PATIENT WITH IMPETIGO HERPETIFORMIS/
Authors: KUIJPERS ALA SCHALKWIJK J RULO HFC PEPERKAMP JJA VANDEKERKHOF PCM DEJONG EMGJ
Citation: Ala. Kuijpers et al., EXTREMELY LOW-LEVELS OF EPIDERMAL SKIN-DERIVED ANTILEUCOPROTEINASE ELAFIN IN A PATIENT WITH IMPETIGO HERPETIFORMIS/, British journal of dermatology, 137(1), 1997, pp. 123-129
THE REGULATION OF CD11B INTEGRIN LEVELS ON HUMAN BLOOD LEUKOCYTES ANDLEUKOTRIENE B4-STIMULATED SKIN BY A SPECIFIC LEUKOTRIENE B4 RECEPTOR ANTAGONIST (LY293111)
Authors: VANPELT JPA DEJONG EMGJ VANERP PEJ MITCHELL MI MARDER P SPAETHE SM VANHOOIJDONK CAEM KUIJPERS ALA VANDEKERKHOF PCM
Citation: Jpa. Vanpelt et al., THE REGULATION OF CD11B INTEGRIN LEVELS ON HUMAN BLOOD LEUKOCYTES ANDLEUKOTRIENE B4-STIMULATED SKIN BY A SPECIFIC LEUKOTRIENE B4 RECEPTOR ANTAGONIST (LY293111), Biochemical pharmacology, 53(7), 1997, pp. 1005-1012
DIFFERENCES IN EXTRACELLULAR-MATRIX PROTEINS, EPIDERMAL GROWTH AND DIFFERENTIATION IN DISCOID LUPUS-ERYTHEMATOSUS, LICHEN-PLANUS AND THE OVERLAP SYNDROME
Authors: DEJONG EMGJ VANDERVLEUTEN CJM VANVLIJMENWILLEMS IMJJ
Citation: Emgj. Dejong et al., DIFFERENCES IN EXTRACELLULAR-MATRIX PROTEINS, EPIDERMAL GROWTH AND DIFFERENTIATION IN DISCOID LUPUS-ERYTHEMATOSUS, LICHEN-PLANUS AND THE OVERLAP SYNDROME, Acta dermato-venereologica, 77(5), 1997, pp. 356-360
ALTERED DISTRIBUTION OF HEPARAN-SULFATE PROTEOGLYCANS IN PSORIASIS
Authors: SEYGER MMB VANDENBORN J SCHALKWIJK J VANDEKERKHOF PCM DEJONG EMGJ
Citation: Mmb. Seyger et al., ALTERED DISTRIBUTION OF HEPARAN-SULFATE PROTEOGLYCANS IN PSORIASIS, Acta dermato-venereologica, 77(2), 1997, pp. 105-109
PSORIASIS OF THE NAILS ASSOCIATED WITH DISABILITY IN A LARGE NUMBER OF PATIENTS - RESULTS OF A RECENT INTERVIEW WITH 1,728 PATIENTS
Authors: DEJONG EMGJ SEEGERS BAMPA GULINCK MK BOEZEMAN JBM VANDEKERKHOF PCM
Citation: Emgj. Dejong et al., PSORIASIS OF THE NAILS ASSOCIATED WITH DISABILITY IN A LARGE NUMBER OF PATIENTS - RESULTS OF A RECENT INTERVIEW WITH 1,728 PATIENTS, Dermatology, 193(4), 1996, pp. 300-303
EFFECTS OF CALCIPOTRIOL AND CLOBETASOL-17-PROPIONATE ON UVB-IRRADIATED HUMAN SKIN - AN IMMUNOHISTOCHEMICAL STUDY
Authors: VANDERVLEUTEN CJM SNIJDERS CGEM DEJONG EMGJ VANDEKERKHOF PCM
Citation: Cjm. Vandervleuten et al., EFFECTS OF CALCIPOTRIOL AND CLOBETASOL-17-PROPIONATE ON UVB-IRRADIATED HUMAN SKIN - AN IMMUNOHISTOCHEMICAL STUDY, Skin pharmacology, 9(6), 1996, pp. 355-365
WHAT IS NEW IN THE TREATMENT OF PSORIASIS
Authors: VANDEKERKHOF PCM GERRITSEN MJP VANDOORENGREEBE RJ DEJONG EMGJ
Citation: Pcm. Vandekerkhof et al., WHAT IS NEW IN THE TREATMENT OF PSORIASIS, Journal of dermatological treatment, 7(4), 1996, pp. 255-259
POSSIBLE INDICATIONS FOR VITAMIN-D-3 ANALOGS IN CONDITIONS OTHER THANPSORIASIS-VULGARIS
Authors: VANDEKERKHOF PCM WITTENHORST M GERRITSEN MJP DEJONG EMGJ LUCKER GPH STEYLEN PM
Citation: Pcm. Vandekerkhof et al., POSSIBLE INDICATIONS FOR VITAMIN-D-3 ANALOGS IN CONDITIONS OTHER THANPSORIASIS-VULGARIS, Journal of dermatological treatment, 7(3), 1996, pp. 195-198
Risultati: 1-25 | 26-40